Cargando…

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection

Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) was first identified in 2012, and it continues to threaten human health worldwide. No MERS vaccines are licensed for human use, reinforcing the urgency to develop safe and efficacious vaccines to prevent MERS. MERS-CoV spike protein form...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tai, Wanbo, Zhao, Guangyu, Sun, Shihun, Guo, Yan, Wang, Yufei, Tao, Xinrong, Tseng, Chien-Te K., Li, Fang, Jiang, Shibo, Du, Lanying, Zhou, Yusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167628/ https://www.ncbi.nlm.nih.gov/pubmed/27750111 http://dx.doi.org/10.1016/j.virol.2016.10.005

Ejemplares similares

Intranasally administered peptidic viral fusion inhibitor protected hDPP4 transgenic mice from MERS-CoV infection
por: Jiang, Shibo, et al.
Publicado: (2015)

Vaccines for the prevention against the threat of MERS-CoV
por: Du, Lanying, et al.
Publicado: (2016)

Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
por: Jiang, Yuting, et al.
Publicado: (2018)

Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV
por: Jiang, Yuting, et al.
Publicado: (2019)

DPP4-directed therapeutic strategies for MERS-CoV
por: Reinhold, Dirk, et al.
Publicado: (2014)

Adaptive Evolution of MERS-CoV to Species Variation in DPP4
por: Letko, Michael, et al.
Publicado: (2018)

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
por: Zhou, Yusen, et al.
Publicado: (2019)

A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2013)

MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2023)

Advances in mRNA and other vaccines against MERS-CoV
por: Tai, Wanbo, et al.
Publicado: (2022)

Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2022)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
por: Fan, Changfa, et al.
Publicado: (2018)

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020)

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020)

A Novel Dynamic Model Describing the Spread of the MERS-CoV and the Expression of Dipeptidyl Peptidase 4
por: Tang, Siming, et al.
Publicado: (2017)

A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
por: Zhao, Guangyu, et al.
Publicado: (2018)

Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein
por: Fukuma, Aiko, et al.
Publicado: (2015)

MERS-CoV
por: Müller, Marcel A
Publicado: (2014)

Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry
por: Song, Wenfei, et al.
Publicado: (2014)

Receptor-binding domain-based subunit vaccines against MERS-CoV
por: Zhang, Naru, et al.
Publicado: (2015)

Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023)

The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014)

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
por: Wang, Nianshuang, et al.
Publicado: (2013)

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017)

MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
por: Reusken, Chantal B.E.M., et al.
Publicado: (2016)

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
por: Ma, Cuiqing, et al.
Publicado: (2014)

The characteristics of hDPP4 transgenic mice subjected to aerosol MERS coronavirus infection via an animal nose‐only exposure device
por: Hao, Xin‐yan, et al.
Publicado: (2019)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

The dipeptidyl peptidase-4 expression in some MERS-CoV naturally infected dromedary camels in Saudi Arabia 2018–2019
por: Alnaeem, Abdelmohsen, et al.
Publicado: (2020)

Development of Small-Molecule MERS-CoV Inhibitors
por: Liang, Ruiying, et al.
Publicado: (2018)

MERS-CoV diagnosis: An update
por: Al Johani, Sameera, et al.
Publicado: (2016)

Mers-CoV and Zika Virus
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

MERS-CoV: in search of answers
por: Petherick, Anna
Publicado: (2013)

Molecular aspects of MERS-CoV
por: Rabaan, Ali A., et al.
Publicado: (2017)

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017)

Unraveling DPP4 Receptor Interactions with SARS-CoV-2 Variants and MERS-CoV: Insights into Pulmonary Disorders via Immunoinformatics and Molecular Dynamics
por: Roy, Arpan Narayan, et al.
Publicado: (2023)

Co‐localization of Middle East respiratory syndrome coronavirus (MERS‐CoV) and dipeptidyl peptidase‐4 in the respiratory tract and lymphoid tissues of pigs and llamas
por: Te, Nigeer, et al.
Publicado: (2018)

NeoCoV Is Closer to MERS-CoV than SARS-CoV
por: Hassan, Mohamed M, et al.
Publicado: (2020)

Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread
por: Lu, Lu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0djs193j3gni916ma4u80c2h6k